The global Procalcitonin (CAS 56645-65-9) market is valued at 62 million US$ in 2018 is expected to reach 93 million US$ by the end of 2025, growing at a CAGR of 5.2% during 2019-2025.
Los Angeles, United States - August 20, 2019 /MarketersMedia/ —
The research study presented here is an intelligent take on the global Procalcitonin Market that explains important aspects such as competition, segmentation, and regional growth in great detail. Accuracy and preciseness are two of the key features of the report that reflect its authenticity. The authors of the report have focused on SWOT analysis, Porter’s Five Forces analysis, and PESTLE analysis of the global Procalcitonin market. In addition, they have concentrated on qualitative and quantitative analyses to help with a deep understanding of the global Procalcitonin market. Furthermore, the report provides powerful suggestions and recommendations to help players create strong growth strategies and ensure impressive sales in the global Procalcitonin market.
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
Get PDF template of this report at https://www.qyresearch.com/sample-form/form/949271/global-procalcitonin-cas-56645-65-9-market
Expressed in E.coli, PCT can be used as a reagent to prepare calibrators for procalcitonin or calcitonin immunoassays. The global procalcitonin market had reached 126.4 g in 2016 and is expected to increase reach 212.6 g by 2023. In terms of revenue, the global procalcitonin chloride market was valued 61.85 Million USD in 2016 and is estimated to be worth 92.27 Million USD by 2023. Overall, the procalcitonin products performance is positive with the global economic recovery.
The manufacture region is concentrated in the USA, Europe, China and Japan, of which Europe is the largest region with the share of 36.92% in 2016. The production shares of Europe, China and Japan were 23.07%, 19.12% and 6.43%.
The consumption share of North America, Europe, Asia Pacific were 26.73%, 28.27%, 35.77% in 2016. The Asia Pacific is the main export region.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in the Procalcitonin market will become more intense.
The global Procalcitonin (CAS 56645-65-9) market is valued at 62 million US$ in 2018 is expected to reach 93 million US$ by the end of 2025, growing at a CAGR of 5.2% during 2019-2025.
This report focuses on Procalcitonin (CAS 56645-65-9) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Procalcitonin (CAS 56645-65-9) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At the company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Beijing Apis
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Procalcitonin Antigen
Procalcitonin Antibody
Segment by Application
Medical Industry
Scientific Research
Request Customization of Report at https://www.qyresearch.com/customize-request/form/949271/global-procalcitonin-cas-56645-65-9-market
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.
Contact Info:
Name: Rahul Singh
Email: Send Email
Organization: QY Research, Inc
Address: QY Research, INC. 17890 Castleton, Suite 218, Los Angeles, CA - 91748
Phone: 6264288800
Website: https://www.qyresearch.com/index/detail/949271/global-procalcitonin-cas-56645-65-9-market
Source: MarketersMedia
Release ID: 88909960
